BANK OF AMERICA CORP /DE/ - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 18 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$10,201
-20.6%
82,259
-34.1%
0.00%
Q4 2022$12,849
-80.8%
124,747
-71.8%
0.00%
Q3 2022$67,000
+857.1%
442,364
+5530.9%
0.00%
Q2 2022$7,000
-96.4%
7,856
-94.9%
0.00%
Q1 2022$192,000
-81.6%
155,077
-71.0%
0.00%
Q4 2021$1,044,000
+52100.0%
535,334
+63935.2%
0.00%
Q3 2021$2,000
-71.4%
836
-63.9%
0.00%
Q2 2021$7,000
+600.0%
2,316
+200.4%
0.00%
Q3 2019$1,000771
+12750.0%
0.00%
Q2 2018$06
-91.5%
0.00%
Q3 2016$0
-100.0%
71
-89.1%
0.00%
Q2 2016$3,0006490.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Performa Ltd (US), LLC 4,900$9,1630.01%
View complete list of VISTAGEN THERAPEUTICS INC shareholders